S902 Intestinal Ultrasound Response and Transmural Remission After 48 Weeks of Treatment With Ustekinumab in Crohn's Disease: STARDUST Trial Substudy Results by Line of Treatment and by Location. (October 2021) - Kucharzik, Torsten